link
Bookmarks
Breast Cancer Staging
Paige Bennett, MD; Umesh D. Oza, MD; Kelli Y. Ha, MD
To access 4,300 diagnoses written by the world's leading experts in radiology, please log in or subscribe.Log inSubscribe
0
0
4
0

KEY FACTS

  • Imaging

    • Top Differential Diagnoses

      IMAGING

      • F-18 FDG PET/CT

        • F-18 NaF PET Bone Scan

          DIFFERENTIAL DIAGNOSIS

            PATHOLOGY

            • General Features

              • Staging, Grading, & Classification

                CLINICAL ISSUES

                • Presentation

                  • Demographics

                    • Natural History & Prognosis

                      • Treatment

                        DIAGNOSTIC CHECKLIST

                        • Consider

                          Selected References

                          1. American Joint Committee on Cancer. https://cancerstaging.org. Accessed March 2017.
                          2. De Placido S et al: Imaging tests in staging and surveillance of non-metastatic breast cancer: changes in routine clinical practice and cost implications. Br J Cancer. 116(6):821-827, 2017
                          3. Garcia JR et al: 18F-FDG PET/CT in the staging and management of breast cancer: Value in disease outcome and planning therapy. Clin Nucl Med. 42(3):191-192, 2017
                          4. Liang X et al: MRI and FDG-PET/CT based assessment of axillary lymph node metastasis in early breast cancer: a meta-analysis. Clin Radiol. 72(4):295-301, 2017
                          5. Noritake M et al: Evaluation of the response to breast cancer neoadjuvant chemotherapy using 18F-FDG positron emission mammography compared with whole-body 18F-FDG PET: A prospective observational study. Clin Nucl Med. 42(3):169-175, 2017
                          6. Lee SC et al: Radiologist's role in breast cancer staging: providing key information for clinicians. Radiographics. 34(2):330-42, 2014
                          7. Groheux D et al: Performance of FDG PET/CT in the clinical management of breast cancer. Radiology. 266(2):388-405, 2013
                          8. Chung A et al: Preoperative FDG-PET for axillary metastases in patients with breast cancer. Arch Surg. 141(8):783-8; discussion 788-9, 2006
                          9. Zangheri B et al: PET/CT and breast cancer. Eur J Nucl Med Mol Imaging. 31 Suppl 1:S135-42, 2004
                          10. Eubank WB et al: Detection of locoregional and distant recurrences in breast cancer patients by using FDG PET. Radiographics. 22(1):5-17, 2002
                          Related Anatomy
                          Loading...
                          Related Differential Diagnoses
                          Loading...
                          References
                          Tables

                          Tables

                          KEY FACTS

                          • Imaging

                            • Top Differential Diagnoses

                              IMAGING

                              • F-18 FDG PET/CT

                                • F-18 NaF PET Bone Scan

                                  DIFFERENTIAL DIAGNOSIS

                                    PATHOLOGY

                                    • General Features

                                      • Staging, Grading, & Classification

                                        CLINICAL ISSUES

                                        • Presentation

                                          • Demographics

                                            • Natural History & Prognosis

                                              • Treatment

                                                DIAGNOSTIC CHECKLIST

                                                • Consider

                                                  Selected References

                                                  1. American Joint Committee on Cancer. https://cancerstaging.org. Accessed March 2017.
                                                  2. De Placido S et al: Imaging tests in staging and surveillance of non-metastatic breast cancer: changes in routine clinical practice and cost implications. Br J Cancer. 116(6):821-827, 2017
                                                  3. Garcia JR et al: 18F-FDG PET/CT in the staging and management of breast cancer: Value in disease outcome and planning therapy. Clin Nucl Med. 42(3):191-192, 2017
                                                  4. Liang X et al: MRI and FDG-PET/CT based assessment of axillary lymph node metastasis in early breast cancer: a meta-analysis. Clin Radiol. 72(4):295-301, 2017
                                                  5. Noritake M et al: Evaluation of the response to breast cancer neoadjuvant chemotherapy using 18F-FDG positron emission mammography compared with whole-body 18F-FDG PET: A prospective observational study. Clin Nucl Med. 42(3):169-175, 2017
                                                  6. Lee SC et al: Radiologist's role in breast cancer staging: providing key information for clinicians. Radiographics. 34(2):330-42, 2014
                                                  7. Groheux D et al: Performance of FDG PET/CT in the clinical management of breast cancer. Radiology. 266(2):388-405, 2013
                                                  8. Chung A et al: Preoperative FDG-PET for axillary metastases in patients with breast cancer. Arch Surg. 141(8):783-8; discussion 788-9, 2006
                                                  9. Zangheri B et al: PET/CT and breast cancer. Eur J Nucl Med Mol Imaging. 31 Suppl 1:S135-42, 2004
                                                  10. Eubank WB et al: Detection of locoregional and distant recurrences in breast cancer patients by using FDG PET. Radiographics. 22(1):5-17, 2002